Hospital Pharmacy of North Norway Trust, Tromsø, Norway.
Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Eur J Hosp Pharm. 2020 Jan;27(1):36-42. doi: 10.1136/ejhpharm-2018-001562. Epub 2018 Jul 7.
The main objective was to investigate Y-site compatibility of intravenous drugs with one standard total parenteral nutrition (TPN) admixture for preterm infants. Since micro-precipitation was observed in the water phase after addition of trace elements, the concentration effect on micro-precipitation formation developed as a sub-goal.
Seven drugs (ampicillin, ceftazidime, fluconazole, fosphenytoin, furosemide, metronidazole and paracetamol) were mixed in three mixing ratios with one preterm TPN admixture. Samples were investigated within 1 hour and again after 4 hours. Precipitation was studied in a lipid-free version called TPN by light obscuration, turbidimetry and visual examination. Emulsion stability data were assessed by light obscuration and laser diffraction. pH was measured to assess the theoretical risk of precipitation and emulsion destabilisation. The influence of different concentrations of trace elements on precipitation was investigated by visual examination, turbidimetry and light obscuration.
Ampicillin, ceftazidime, fosphenytoin and furosemide led to precipitation after mixing with TPN. In some samples of TPN and fluconazole, metronidazole and paracetamol, the emulsion droplet size was above the acceptance limit, although this might also be inherent to the TPN admixture. An unexpected formation of micro-precipitate correlating with increasing amounts of added trace elements might be caused by an interaction of cysteine and copper, and complicated the compatibility assessment with drugs.
The micro-precipitate resulting from the addition of trace elements should be investigated further. This study did not provide sufficient evidence to recommend Y-site infusion of the tested drugs and the preterm admixture; however, it might offer some additional support to other compatibility data.
本研究旨在考察与一种标准全肠外营养(TPN)混合液的早产儿用静脉药物的 Y 型部位相容性。由于微量元素添加后水相中观察到微沉淀,因此形成微沉淀的浓度效应是次要目标。
将七种药物(氨苄西林、头孢他啶、氟康唑、苯妥英钠、呋塞米、甲硝唑和对乙酰氨基酚)以三种混合比例与一种早产儿 TPN 混合液混合。样品在 1 小时内进行研究,并在 4 小时后再次进行研究。在无脂版本的 TPN 中通过光浊度法、比浊法和目视检查研究沉淀。通过光浊度法和激光衍射法评估乳剂稳定性数据。测量 pH 值以评估沉淀和乳剂失稳的理论风险。通过目视检查、比浊法和光浊度法研究不同浓度的微量元素对沉淀的影响。
氨苄西林、头孢他啶、苯妥英钠和呋塞米与 TPN 混合后会导致沉淀。在 TPN 和氟康唑、甲硝唑和对乙酰氨基酚的一些样品中,尽管这可能也与 TPN 混合物有关,但乳剂液滴尺寸超过了可接受的范围。与添加的微量元素数量相关的意外微沉淀的形成可能是由于半胱氨酸和铜之间的相互作用引起的,这使药物相容性评估变得复杂。
应进一步研究添加微量元素后形成的微沉淀。本研究没有提供充分的证据推荐使用所测试的药物和早产儿用 TPN 进行 Y 型部位输注;然而,它可能为其他相容性数据提供一些额外的支持。